Skip to main content
Signal8

BioNexus Gene Lab Corp (BGLC)

BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.

Sector: Services-Medical Laboratories

Industry: Industrial - Distribution

BioNexus Gene Lab Corp. logo

BioNexus Gene Lab Corp.

NASDAQ:BGLCIndustrials
AH+0.00%$0.7662
Close$0.7662-6.56%
Mkt Cap$2.25M
EV-
Float1.24M
O/S2.93M
VOL13K sh
$ Vol$10K
RVOL2.36×
Inst Own0.0%
Net Cash/Sh-
Dilution
BioNexus Gene Lab Corp. logoNASDAQ:BGLCAH$0.7662+0.00%

BioNexus Gene Lab Corp (BGLC) dilution facts from SEC filings

Snapshot as of Jun 30, 2026, built from 21 SEC filings.

Shelf registration
S-3 filed Nov 7, 2025, effective Nov 27, 2025
Source: 10-Q filed Aug 14, 2026
At-the-market (ATM) program
Yes, sales agreement dated Nov 7, 2025
Source: 10-Q filed Aug 14, 2026
Warrants outstanding
1 warrant series recorded as outstanding
Most recent offering
Not measured

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro